Case Law On Prosecutions Of Pharmacy Chains
Case 1: Omnicare, Inc. – Kickbacks and False Claims Act Violations
Facts:
Omnicare, a pharmacy servicing nursing homes in the U.S., was accused of offering financial incentives to nursing homes to secure their pharmacy business. These incentives were effectively kickbacks for referrals. They then submitted claims to Medicare and Medicaid for medications, some of which were unnecessary or induced through these improper arrangements.
Legal Issues:
Violation of the Anti-Kickback Statute: providing remuneration in exchange for referrals for services covered by federal programs.
Violation of the False Claims Act (FCA): submitting claims for drugs that were not medically necessary or where the referral was induced by kickbacks.
Outcome:
Omnicare settled for around $124 million in 2014.
Earlier settlements also included $98 million in 2009 for similar kickback violations.
Significance: Demonstrated that financial arrangements with referral sources could lead to enormous liabilities for pharmacy chains.
Case 2: Walgreens – Opioid Prescriptions and Billing Irregularities
Facts:
Walgreens was prosecuted for filling medically unnecessary opioid prescriptions and for billing government programs for prescriptions that were never dispensed. Investigations showed that pharmacists ignored red flags about patients receiving high-risk drug combinations.
Legal Issues:
Violation of the Controlled Substances Act for dispensing opioids without legitimate medical purpose.
Violation of the False Claims Act for billing Medicare/Medicaid for invalid prescriptions.
Outcome:
Walgreens agreed to settlements exceeding $100 million for billing-related violations.
Further settlement for opioid prescription claims reached $300 million.
Significance: Highlighted the chain’s responsibility to monitor controlled substances and maintain compliance with government billing programs.
Case 3: CVS Health / Omnicare – Invalid Prescriptions
Facts:
After acquiring Omnicare in 2015, CVS was implicated in submitting over 3.3 million claims for invalid prescriptions in long-term care facilities. The company failed to prevent Omnicare’s ongoing misconduct.
Legal Issues:
Corporate liability for acquired subsidiaries failing to maintain proper prescription compliance.
False Claims Act violations due to billing for invalid prescriptions.
Outcome:
Judgment totaled approximately $948.8 million, including treble damages and penalties.
Significance: Showed that parent companies could be held accountable for subsidiaries’ compliance failures, particularly in healthcare billing.
Case 4: Medplus (India) – Non-Compliance with Drugs & Cosmetics Act
Facts:
A pharmacy chain in India was prosecuted for failing to maintain proper prescription records for Schedule H1 drugs, including missing prescriber details.
Legal Issues:
Non-compliance with Schedule H1 regulations under the Drugs & Cosmetics Act, requiring pharmacies to maintain detailed prescription logs.
Outcome:
The Madras High Court quashed the criminal complaint, but ordered the chain to maintain proper records going forward.
Significance: Reinforced the importance of accurate record-keeping and adherence to regulatory standards in India.
Case 5: Himachal Pradesh Chemist Conviction (India) – Holding Medicines Without License
Facts:
A chemist was convicted for storing medicines without a valid license, which was deemed “offer for sale” under the Drugs & Cosmetics Act.
Legal Issues:
Offense under Section 18(a) of the Drugs & Cosmetics Act: possession of drugs without a proper license.
Outcome:
High Court upheld the conviction and imposed imprisonment plus fine.
Significance: Demonstrated that even possession or display without proper licensing can result in prosecution, emphasizing strict regulatory compliance.
Case 6: Rite Aid (U.S.) – Billing and Dispensing Fraud
Facts:
Rite Aid, a major U.S. pharmacy chain, was investigated for dispensing medications that were not authorized and billing federal health programs for these prescriptions. This included filling prescriptions without valid physician authorization.
Legal Issues:
Violations of False Claims Act and state anti-fraud laws.
Responsibility for ensuring prescriptions are valid before submitting claims for reimbursement.
Outcome:
Rite Aid agreed to a multi-million-dollar settlement to resolve these claims.
Significance: Highlighted the role of internal compliance and auditing to prevent billing fraud.
Case 7: Boots UK – NHS Dispensing Errors
Facts:
Boots UK faced legal scrutiny for repeated dispensing errors in prescriptions supplied to the NHS, including incorrect dosages and mislabeled medications.
Legal Issues:
Breach of statutory duty under the Pharmacy Act and NHS regulations.
Potential liability for professional negligence due to patient harm.
Outcome:
The company faced fines and was required to implement stricter internal controls.
Significance: Showed that dispensing errors could lead to regulatory and civil liability even in retail pharmacy chains.
Key Takeaways Across Cases
Corporate Responsibility – Parent companies are liable for subsidiaries’ compliance failures.
Record-Keeping & Documentation – Critical for controlled and prescription-only drugs.
Anti-Kickback & Fraud – Financial arrangements influencing prescriptions can trigger major fines.
Controlled Substances Oversight – Pharmacies must monitor red flags and patient safety.
Global Application – Both U.S. and Indian laws stress licensing, accurate prescriptions, and compliance as fundamental.
RELATED Blog
comments